Car T Therapy Market Scope And Analysis

  • Report Code : TIPRE00003731
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Analisi del mercato della terapia CAR-T e dei concorrenti entro il 2025-2031

Buy Now

CAR-T Therapy Market Report CAR-T Therapy Market Size and Share CAR-T Therapy Market Scope and Analysis

CAR-T Therapy Market Report Scope

Report Attribute Details
Market size in XX milioni di dollari USA nel 2024
Market Size by XX milioni di dollari entro il 2031
Global CAGR ()
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Antigene mirato
  • CD 19
  • BCMA
  • HER2
  • GD2
  • CD 20
  • CD22
  • CD30
  • CD33
  • HER1 e altri
By Applicazione terapeutica
  • leucemia linfatica acuta
  • leucemia linfatica cronica
  • linfoma diffuso a grandi cellule B
  • linfoma follicolare
  • mieloma multiplo
  • glioblastoma
  • sarcoma
  • neuroblastoma
  • leucemia mieloide acuta
  • cancro al seno
  • cancro al pancreas
  • carcinoma epatocellulare
  • cancro colorettale e altri
By Geografia
  • Nord America
  • Europa
  • Asia-Pacifico
  • Sud e Centro America
  • Medio Oriente e Africa
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Novartis International AG
  • Kite Pharma, Inc. (Gilead Sciences, Inc.)
  • Juno Therapeutics (Celgene Corporation)
  • Bluebird Bio, Inc. (Celgene Corporation)
  • Sorrento Therapeutics Inc.
  • Mustang Bio, Inc
  • Aurora Biopharma Inc.
  • Legend Biotech (Genscript Biotech Corporation)
  • Pfizer, Inc.